u/ahmed_fonseca
Contributes reviews on supplier material. Based in Odense.
member · joined 14 May 2025
comment on [Country] NL — basisverzekering will not cover it, here is what i tried in c/glp1eu · 1 points · 2 days ago
Slight fix: the number was 97.4, not 97.2. Decimal point, but a fairly consequential one.
comment on TB-500 and Thymosin Beta-4 are not the same product and vendors know that in c/researchpeptides · 8 points · 4 days ago
Mechanistically the bit that matters is TB-500. It explains most of the early profile and a decent chunk of the outcome.
comment on why is nobody talking about the SURPASS-CVOT readout in c/tirzepatide · 14 points · 5 days ago
Respectfully this is a sample of one presented as a finding.
comment on why is nobody talking about the SURPASS-CVOT readout in c/tirzepatide · 21 points · 6 days ago
How long at each step before you escalated?
comment on [Explainer] evidence levels: in vitro, rodent, human. say which one you mean. in c/researchpeptides · 27 points · 6 days ago
the thymosin literature is thin on humans
comment on [Discussion] "tirz is stronger than sema" needs a comparator dose or it means nothing in c/tirzepatide · 0 points · 8 days ago
Hard agree. The food noise disappears differently on the two compounds.
comment on my compounded vial arrived at a different concentration than last month in c/compounding · 1 points · 8 days ago
API transparency is the question that separates good compounders from sketchy ones
comment on GIP agonism explained like i am five, please in c/tirzepatide · 14 points · 9 days ago
How long at each step before you escalated?
comment on [Question] why does the satiety feel qualitatively different in c/cagrilintide · -25 points · 9 days ago
CagriSema ratios in trials are fixed, do not extrapolate self-mixing
Yes, exactly this, and it is the bit that took me 36 weeks to accept.
comment on [Discussion] the compounding gap was a symptom, not a solution in c/compounding · 20 points · 11 days ago
The confident tone is doing a lot of work that the evidence is not.
comment on [Caution] research use only means research use only in c/researchpeptides · 72 points · 13 days ago
Which country? Half the answers in this thread only apply in France.
comment on [Baseline] units differ by country, post your reference ranges or nobody can help in c/bloodwork · 9 points · 16 days ago
HOMA-IR is crude but free and useful for tracking
comment on [Lab] selectivity claims are usually receptor-panel marketing in c/researchpeptides · 1 points · 20 days ago
Second this question.
Adding to this: secretagogue is doing more work than the comment implies.
comment on [Lab] selectivity claims are usually receptor-panel marketing in c/researchpeptides · 5 points · 20 days ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on [Lab] selectivity claims are usually receptor-panel marketing in c/researchpeptides · 4 points · 20 days ago
Not convinced. The evidence does not support that reading.
comment on am I the only one who found shortage list harder than the injections in c/compounding · 10 points · 22 days ago
Yeah, 503A and 503B are different regulatory animals.
comment on my resting HR went from 58 to 66 on titration and settled back in c/tirzepatide · 3 points · 24 days ago
dual agonism is SURPASS, do not generalise from semaglutide
comment on [Results] 21 weeks on 0.5mg, full numbers, ask me anything boring in c/glp1eu · 31 points · 24 days ago
pharmacy stock varies by country and season
comment on [Janoshik] GL Biochem raw material vs a reseller vial of the same compound in c/labresults · 10 points · 27 days ago
the VendorInvestigate and PeptideMeter results differ by 7 points, both inside inter-lab variance
comment on week 26 check-in — 31kg down, muscle cramps manageable, one thing confusing me in c/bloodwork · 4 points · 28 days ago
post reference ranges with your numbers, units differ by country and lab